$LSF
Laird Superfood, Inc. Stock $lsf

$lsf Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-K Financial Statement

#000095017022003138 Filed on March 08, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q3
Revenue	$9.340M	$9.368M	$10.87M
YoY Change	26.27%	28.59%	45.06%
Cost Of Revenue	$7.390M	$7.154M	$7.667M
YoY Change	32.93%	22.92%	33.71%
Gross Profit	$1.950M	$2.214M	$3.199M
YoY Change	6.12%	51.11%	82.11%
Gross Profit Margin	20.88%	23.63%	29.44%
Selling, General & Admin	$15.80M	$9.060M	$8.269M
YoY Change	127.63%	55.46%	64.21%
% of Gross Profit	810.35%	409.26%	258.5%
Research & Development	$103.8K	$172.0K	$242.6K
YoY Change	-56.86%	19.28%	135.81%
% of Gross Profit	5.33%	7.77%	7.58%
Depreciation & Amortization	$142.8K	$283.6K	$152.1K
YoY Change	8.75%	117.4%	32.44%
% of Gross Profit	7.32%	12.81%	4.76%
Operating Expenses	$15.90M	$9.232M	$8.511M
YoY Change	121.45%	54.59%	65.65%
Operating Profit	-$13.95M	-$7.018M	-$5.313M
YoY Change	161.1%	55.72%	57.09%
Interest Expense	-$177.4K	$12.46K	$10.72K
YoY Change	-1376.26%	-7.15%	-59.93%
% of Operating Profit
Other Income/Expense, Net	-$179.3K	$51.00K	$10.72K
YoY Change	-1389.99%		-59.92%
Pretax Income	-$14.13M	-$6.955M	-$5.302M
YoY Change	165.15%	54.77%	58.03%
Income Tax	$5.774K	$68.66K	-$49.78K
% Of Pretax Income
Net Earnings	-$14.14M	-$6.886M	-$5.352M
YoY Change	165.25%	53.24%	59.51%
Net Earnings / Revenue	-151.39%	-73.51%	-49.25%
Basic Earnings Per Share	-$1.55	$0.76	-$0.59
Diluted Earnings Per Share	-$1.55	-$759.3K	-$0.59
COMMON SHARES
Basic Shares Outstanding	9.093M	9.054M	9.002M
Diluted Shares Outstanding	9.095M	9.067M	9.002M

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$27.16M	$31.57M	$39.62M
YoY Change	-54.88%	-51.94%	-46.04%
Cash & Equivalents	$27.16M	$22.93M	$30.93M
Short-Term Investments	$0.00	$8.635M	$8.688M
Other Short-Term Assets	$197.9K	$459.6K	$378.4K
YoY Change	243.86%	799.28%	579.97%
Inventory	$9.856M	$10.22M	$10.34M
Prepaid Expenses
Receivables	$1.262M	$1.269M	$956.9K
Other Receivables	$300.7K	$679.9K	$563.6K
Total Short-Term Assets	$41.73M	$47.68M	$53.37M
YoY Change	-42.28%	-37.26%	-33.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.497M	$4.513M	$4.139M
YoY Change	28.43%	28.45%	28.99%
Goodwill	$0.00	$6.486M	$6.486M
YoY Change
Intangibles	$3.157M	$4.839M	$4.965M
YoY Change		3429.64%
Long-Term Investments
YoY Change
Other Assets	$947.4K	$2.328M	$2.429M
YoY Change	1115.82%	46529.61%	32095.92%
Total Long-Term Assets	$16.00M	$18.17M	$18.02M
YoY Change	153.24%	186.2%	182.2%
TOTAL ASSETS
Total Short-Term Assets	$41.73M	$47.68M	$53.37M
Total Long-Term Assets	$16.00M	$18.17M	$18.02M
Total Assets	$57.73M	$65.85M	$71.39M
YoY Change	-26.57%	-20.03%	-17.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$965.9K	$888.8K	$1.548M
YoY Change	-39.65%	-32.46%	-33.8%
Accrued Expenses	$2.222M	$2.083M	$1.186M
YoY Change	159.01%	195.67%	36.6%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.319M	$3.786M	$3.548M
YoY Change	53.24%	38.0%	-9.16%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$51.00K
YoY Change	-100.0%	-100.0%	0.0%
Other Long-Term Liabilities	$4.407M
YoY Change
Total Long-Term Liabilities	$4.407M	$7.534K	$137.5K
YoY Change	8541.98%	-85.23%	169.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.319M	$3.786M	$3.548M
Total Long-Term Liabilities	$4.407M	$7.534K	$137.5K
Total Liabilities	$9.726M	$3.794M	$3.685M
YoY Change	176.17%	35.75%	-6.86%
SHAREHOLDERS EQUITY
Retained Earnings	-$69.94M	-$55.80M	-$48.91M
YoY Change	87.71%	74.77%	78.29%
Common Stock	$117.9M	$117.9M	$116.6M
YoY Change	4.97%	5.79%	5.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$48.00M	$62.05M	$67.70M
YoY Change
Total Liabilities & Shareholders Equity	$57.73M	$65.85M	$71.39M
YoY Change	-26.57%	-20.03%	-17.7%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q3
OPERATING ACTIVITIES
Net Income	-$14.14M	-$6.886M	-$5.352M
YoY Change	165.25%	53.24%	59.51%
Depreciation, Depletion And Amortization	$142.8K	$283.6K	$152.1K
YoY Change	8.75%	117.4%	32.44%
Cash From Operating Activities	-$3.602M	-$7.853M	-$3.290M
YoY Change	-29.97%	3.52%	34.23%
INVESTING ACTIVITIES
Capital Expenditures	$701.9K	-$531.2K	-$548.5K
YoY Change	472.56%	186.95%	-2.4%
Acquisitions
YoY Change
Other Investing Activities	$8.514M	-$15.85K	-$55.09K
YoY Change	1216154.29%	-99.81%	-101.27%
Cash From Investing Activities	$7.812M	-$547.0K	-$603.6K
YoY Change	-4004.23%	-93.49%	-116.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	14.25K	391.5K	91.28K
YoY Change	-111.95%	60.35%	-99.86%
NET CHANGE
Cash From Operating Activities	-3.602M	-7.853M	-3.290M
Cash From Investing Activities	7.812M	-547.0K	-603.6K
Cash From Financing Activities	14.25K	391.5K	91.28K
Net Change In Cash	4.224M	-8.008M	-3.802M
YoY Change	-177.33%	-49.12%	-105.9%
FREE CASH FLOW
Cash From Operating Activities	-$3.602M	-$7.853M	-$3.290M
Capital Expenditures	$701.9K	-$531.2K	-$548.5K
Free Cash Flow	-$4.304M	-$7.322M	-$2.741M
YoY Change	-18.27%	-1.07%	45.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q4	us-gaap	Goodwill Goodwill	0
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001650696
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-39537
CY2021	dei	Entity Registrant Name EntityRegistrantName	Laird Superfood, Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-1589788
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	275 W. Lundgren Mill Drive
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Sisters
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	OR
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	97759
CY2021	dei	City Area Code CityAreaCode	888
CY2021	dei	Local Phone Number LocalPhoneNumber	670-6796
CY2021	dei	Security12b Title Security12bTitle	Common Stock
CY2021	dei	Trading Symbol TradingSymbol	LSF
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q4	us-gaap	Deposit Assets DepositAssets	679919
CY2021Q4	us-gaap	Assets Current AssetsCurrent	47681834
CY2020Q4	us-gaap	Deposit Assets DepositAssets	97674
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	125000000
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9092890
CY2021	dei	Auditor Firm AuditorFirmId	659
CY2021	dei	Auditor Name AuditorName	Moss Adams LLP
CY2021	dei	Auditor Location AuditorLocation	Portland, Oregon, USA
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23049234
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57208080
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1268718
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	839659
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	8635077
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	8706844
CY2021Q4	us-gaap	Inventory Net InventoryNet	10221343
CY2020Q4	us-gaap	Inventory Net InventoryNet	6295898
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3827543
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2847319
CY2020Q4	us-gaap	Assets Current AssetsCurrent	75995474
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4512935
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3513488
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4838854
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	137092
CY2021Q4	us-gaap	Goodwill Goodwill	6486000
CY2021Q4	us-gaap	Deferred Rent Receivables Net Noncurrent DeferredRentReceivablesNetNoncurrent	2327752
CY2020Q4	us-gaap	Deferred Rent Receivables Net Noncurrent DeferredRentReceivablesNetNoncurrent	2696646
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	18165541
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	6347226
CY2021Q4	us-gaap	Assets Assets	65847375
CY2020Q4	us-gaap	Assets Assets	82342700
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	888768
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1315964
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	814163
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	722915
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2083090
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	704543
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3786021
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2743422
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7534
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31927168
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	62053820
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	79548278
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	51000
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7534
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	51000
CY2021Q4	us-gaap	Liabilities Liabilities	3793555
CY2020Q4	us-gaap	Liabilities Liabilities	2794422
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9460243
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9094539
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9247758
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8892886
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	9095
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	8893
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	117903455
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	111452346
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-61016
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	14207
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55797714
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	65847375
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	82342700
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36810953
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25783226
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	27379082
CY2021	lsf	Stock Based Compensation Sales And Marketing StockBasedCompensationSalesAndMarketing	228968
CY2020	lsf	Stock Based Compensation Sales And Marketing StockBasedCompensationSalesAndMarketing	661026
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	19204642
CY2021	us-gaap	Gross Profit GrossProfit	9431871
CY2020	us-gaap	Gross Profit GrossProfit	6578584
CY2021	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	4822910
CY2020	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	3546489
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3569416
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1424803
CY2021	us-gaap	Professional Fees ProfessionalFees	2232171
CY2020	us-gaap	Professional Fees ProfessionalFees	963791
CY2021	us-gaap	General Insurance Expense GeneralInsuranceExpense	2140208
CY2020	us-gaap	General Insurance Expense GeneralInsuranceExpense	666045
CY2021	lsf	Office Expenses OfficeExpenses	1217651
CY2020	lsf	Office Expenses OfficeExpenses	735669
CY2021	us-gaap	Occupancy Net OccupancyNet	430148
CY2020	us-gaap	Occupancy Net OccupancyNet	612998
CY2021	lsf	Merchant Service Fees MerchantServiceFees	598657
CY2020	lsf	Merchant Service Fees MerchantServiceFees	375792
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1448101
CY2020	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	502692
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16459262
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8828279
CY2021	lsf	Research And Development Expenses Salaries And Wages ResearchAndDevelopmentExpensesSalariesAndWages	421521
CY2020	lsf	Research And Development Expenses Salaries And Wages ResearchAndDevelopmentExpensesSalariesAndWages	272605
CY2021	lsf	Research And Development Expenses Stock Based Compensation ResearchAndDevelopmentExpensesStockBasedCompensation	23561
CY2020	lsf	Research And Development Expenses Stock Based Compensation ResearchAndDevelopmentExpensesStockBasedCompensation	10261
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	566695
CY2020	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	209275
CY2021	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	18350
CY2020	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	16029
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1030127
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	508170
CY2021	lsf	Salaries And Wages Sales And Marketing SalariesAndWagesSalesAndMarketing	2529231
CY2020	lsf	Salaries And Wages Sales And Marketing SalariesAndWagesSalesAndMarketing	2669384
CY2021	us-gaap	Advertising Expense AdvertisingExpense	7570879
CY2020	us-gaap	Advertising Expense AdvertisingExpense	4257963
CY2021	us-gaap	Marketing Expense MarketingExpense	4491446
CY2020	us-gaap	Marketing Expense MarketingExpense	1568258
CY2020	lsf	Adjustment To Additional Paid In Capital Temporary Equity Beneficial Conversion Feature AdjustmentToAdditionalPaidInCapitalTemporaryEquityBeneficialConversionFeature	825366
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-23870546
CY2021	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	1074374
CY2020	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	1014675
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15894898
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10171306
CY2021	us-gaap	Operating Expenses OperatingExpenses	33384287
CY2020	us-gaap	Operating Expenses OperatingExpenses	19507755
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-23952416
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-12929171
CY2021	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	48704
CY2020	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	64943
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment	0
CY2020	us-gaap	Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment	13927
CY2021	lsf	Grant Income GrantIncome	51000
CY2020	lsf	Grant Income GrantIncome	0
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	99704
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	78870
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23852712
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12850301
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-17834
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-12850301
CY2021	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	0
CY2020	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	825366
CY2021	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	0
CY2020	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	825366
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-23870546
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14501033
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.66
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.61
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.66
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.61
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8983294
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	5546078
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-23870546
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14501033
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-75223
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	14433
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-75223
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	14433
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23795323
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14515466
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	8111345
CY2020	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2318502
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	259747
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	20532
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-23870546
CY2020	lsf	Adjustment To Additional Paid In Capital Deemed Dividend On Beneficial Conversion Feature AdjustmentToAdditionalPaidInCapitalDeemedDividendOnBeneficialConversionFeature	-825366
CY2020	lsf	Adjustment To Additional Paid In Capital Allocation Of Preferred Proceeds To Warrant AdjustmentToAdditionalPaidInCapitalAllocationOfPreferredProceedsToWarrant	825366
CY2020	lsf	Adjustment To Additional Paid In Capital Deemed Dividend On Warrant Discount AdjustmentToAdditionalPaidInCapitalDeemedDividendOnWarrantDiscount	-825366
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	16575236
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	66110517
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1268772
CY2020	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	298103
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	14433
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-12850301
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	79548278
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4040207
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	219158
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	810656
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	82043
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	48
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1834857
CY2021	lsf	Employee Stock Purchase Plan Shares Issued EmployeeStockPurchasePlanSharesIssued	66744
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-75223
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	62053820
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-23870546
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-12850301
CY2021	us-gaap	Depreciation Depreciation	596505
CY2020	us-gaap	Depreciation Depreciation	474621
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	385093
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	10152
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	6400
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	4040207
CY2020	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	2318502
CY2021	lsf	Reserve For Prepaid Assets ReserveForPrepaidAssets	179000
CY2020	lsf	Reserve For Prepaid Assets ReserveForPrepaidAssets	0
CY2021	us-gaap	Restricted Stock Expense RestrictedStockExpense	0
CY2020	us-gaap	Restricted Stock Expense RestrictedStockExpense	62431
CY2021	lsf	Noncash Conversion Of Note Payable To Grant Income NoncashConversionOfNotePayableToGrantIncome	51000
CY2020	lsf	Noncash Conversion Of Note Payable To Grant Income NoncashConversionOfNotePayableToGrantIncome	0
CY2021	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	8317
CY2020	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	239734
CY2021	lsf	Increase Decrease In Deferred Taxes IncreaseDecreaseInDeferredTaxes	7534
CY2020	lsf	Increase Decrease In Deferred Taxes IncreaseDecreaseInDeferredTaxes	0
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0
CY2020	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-13927
CY2021	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	382970
CY2020	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	454853
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3199439
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3859932
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	922058
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2256511
CY2021	lsf	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-368894
CY2020	lsf	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-360786
CY2021	lsf	Increase Decrease In Deposits Assets IncreaseDecreaseInDepositsAssets	86920
CY2020	lsf	Increase Decrease In Deposits Assets IncreaseDecreaseInDepositsAssets	-30954
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-474519
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	591213
CY2021	us-gaap	Increase Decrease In Due To Employees Current IncreaseDecreaseInDueToEmployeesCurrent	82059
CY2020	us-gaap	Increase Decrease In Due To Employees Current IncreaseDecreaseInDueToEmployeesCurrent	231824
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1230436
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	403481
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22095807
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14683972
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1555191
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1059858
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	12700
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0
CY2021	lsf	Payments Towards Advances On Property Plant And Equipment To Be Acquired PaymentsTowardsAdvancesOnPropertyPlantAndEquipmentToBeAcquired	489325
CY2020	lsf	Payments Towards Advances On Property Plant And Equipment To Be Acquired PaymentsTowardsAdvancesOnPropertyPlantAndEquipmentToBeAcquired	0
CY2021	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	156855
CY2020	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	0
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	10449587
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	1028
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	8171129
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	4950000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12639286
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4280987
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	66744
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	66110517
CY2021	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	0
CY2020	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	10000006
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	82043
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1268772
CY2021	lsf	Preferred Stock Issuance Costs PreferredStockIssuanceCosts	0
CY2020	lsf	Preferred Stock Issuance Costs PreferredStockIssuanceCosts	147721
CY2021	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	0
CY2020	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	298103
CY2021	lsf	Proceeds From Restricted Stock Units Issued ProceedsFromRestrictedStockUnitsIssued	48
CY2020	lsf	Proceeds From Restricted Stock Units Issued ProceedsFromRestrictedStockUnitsIssued	0
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	219158
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	20532
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	810656
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	197329
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	576247
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	75168930
CY2021	us-gaap	Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-34158846
CY2020	us-gaap	Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	56203971
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57208080
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1004109
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23049234
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57208080
CY2021	lsf	Supplemental Noncash Conversion Of Note Payable To Grant Income SupplementalNoncashConversionOfNotePayableToGrantIncome	51000
CY2020	lsf	Supplemental Noncash Conversion Of Note Payable To Grant Income SupplementalNoncashConversionOfNotePayableToGrantIncome	0
CY2021	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-75223
CY2020	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	14433
CY2021	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	1834857
CY2020	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	16575236
CY2021Q4	lsf	Purchases Of Equipment Included In Deposits PurchasesOfEquipmentIncludedInDeposits	0
CY2020Q4	lsf	Purchases Of Equipment Included In Deposits PurchasesOfEquipmentIncludedInDeposits	14699
CY2021	us-gaap	Equipment Expense EquipmentExpense	26141
CY2020	us-gaap	Equipment Expense EquipmentExpense	0
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:Times New Roman;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Although management believes its estimates and assumptions are reasonable when made, they are based upon information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes adjustments. Due to the risks and uncertainties involved in the Company’s business and evolving market conditions and given the subjective element of the estimates and assumptions made, actual results may differ from estimated results. The most significant estimates and judgments include those related to the business combination, allowances for doubtful accounts and returns, inventory obsolescence, goodwill, intangible assets, valuation allowance for deferred taxes, reserves on prepaid expenses, and fair value of stock-based compensation.</span></p>
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22932663
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56973896
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	116571
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	234184
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23049234
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57208080
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:Times New Roman;font-style:italic;">Concentration of Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash on deposit and cash equivalents. At times, cash and cash equivalents balances may exceed the Federal Deposit Insurance Corporation (“FDIC”) insurable limits. The Company’s investment account (recognized as cash and cash equivalents) is with what the Company believes to be a high-quality issuer. The Company has never experienced any losses related to these balances. Non-interest-bearing amounts on deposit in excess of FDIC insurable limits as of December 31, 2021 and 2020 approximated $</span><span style="font-size:9.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:Times New Roman;">10,835,360</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:Times New Roman;"> and $</span><span style="font-size:9.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:Times New Roman;">6,639,821</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:Times New Roman;">, respectively.</span></p>
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	10835360
CY2020Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	6639821
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2020Q4	us-gaap	Inventory Net InventoryNet	6295898
CY2020Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	958166
CY2021	us-gaap	Marketing Expense MarketingExpense	4491446
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	4771671
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	4109706
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5449672
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2186192
CY2021Q4	us-gaap	Inventory Net InventoryNet	10221343
CY2021Q4	lsf	Advances For Future Equipment Purchases AdvancesForFutureEquipmentPurchases	489325
CY2020Q4	lsf	Advances For Future Equipment Purchases AdvancesForFutureEquipmentPurchases	0
CY2021Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	253750
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1030127
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	508170
CY2021	us-gaap	Advertising Expense AdvertisingExpense	7570879
CY2020	us-gaap	Advertising Expense AdvertisingExpense	4257963
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	152324
CY2020	us-gaap	Marketing Expense MarketingExpense	1568258
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13124828
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7563110
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7534
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	20532
CY2021	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	The Company’s board of directors and stockholders approved a 2-for-1 split of the Company’s common stock, which was effected on August 19, 2020. The split divided each share of the Company’s issued and outstanding common stock into two shares of common stock and correspondingly adjusted the conversion prices of its convertible preferred stock. No fractional shares were issued in connection with the split.
CY2021Q4	lsf	Prepaid Consultancy Fees Current PrepaidConsultancyFeesCurrent	0
CY2020Q4	lsf	Prepaid Consultancy Fees Current PrepaidConsultancyFeesCurrent	13962
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2021Q4	lsf	Prepaid Software Costs PrepaidSoftwareCosts	455781
CY2020Q4	lsf	Prepaid Software Costs PrepaidSoftwareCosts	225567
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	240657
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:Times New Roman;font-style:italic;">Reclassification of Prior Period Presentation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:Times New Roman;">Certain prior period amounts have been reclassified for consistency with the current year presentation. As a result, certain line items have been amended in the balance sheets, statements of operations, statements of cash flow, and the related notes to the consolidated financial statements with no impact to overall net loss.</span></p>
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1586768
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1446189
CY2021Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	1009954
CY2020Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	958166
CY2020Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	0
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	459633
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	51111
CY2021Q4	lsf	Prepaid Expense And Other Assets Current Gross PrepaidExpenseAndOtherAssetsCurrentGross	4006543
CY2020Q4	lsf	Prepaid Expense And Other Assets Current Gross PrepaidExpenseAndOtherAssetsCurrentGross	2847319
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	179000
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3827543
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2847319
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	8696093
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	8635077
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	8696093
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	8635077
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	51000
CY2017Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	51000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5960310
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4407853
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1447375
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	894365
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4512935
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3513488
CY2021Q4	us-gaap	Goodwill Goodwill	6486000
CY2020Q4	us-gaap	Goodwill Goodwill	0
CY2021Q4	us-gaap	Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount	0.50
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5118662
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	31807
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	411908
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	26815
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4706754
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4992
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4838854
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	137092
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	385093
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10152
CY2021	us-gaap	Finite Lived Intangible Assets Amortization Method FiniteLivedIntangibleAssetsAmortizationMethod	straight-line method
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	565441
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	564139
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	508268
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	485120
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	485120
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2098666
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4706754
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	685670
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	696286
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	717174
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	738689
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	760849
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	3105990
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	6704658
CY2021	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1180028
CY2020	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	856680
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4972657
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	3519871
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4987902
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2978937
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	105126
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	592048
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	102537
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	51114
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-17834
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0008
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	11999882
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	7444857
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	686601
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	671562
CY2021Q4	lsf	Deferred Tax Assets Federal Depreciation And Amortisation DeferredTaxAssetsFederalDepreciationAndAmortisation	165216
CY2020Q4	lsf	Deferred Tax Assets Federal Depreciation And Amortisation DeferredTaxAssetsFederalDepreciationAndAmortisation	106526
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	98296
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	75702
CY2021Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	38447
CY2020Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	0
CY2021Q4	lsf	Deferred Tax Assets Unexercised Options DeferredTaxAssetsUnexercisedOptions	679688
CY2020Q4	lsf	Deferred Tax Assets Unexercised Options DeferredTaxAssetsUnexercisedOptions	0
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	13668130
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	8298647
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	568787
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	735537
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	17951
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	550836
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	735537
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	13117294
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7563110
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13124828
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7563110
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7534
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7534
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	10300
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5561718
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	48037477
CY2020Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	28188867
CY2021Q4	us-gaap	Deferred Credits And Other Liabilities Noncurrent DeferredCreditsAndOtherLiabilitiesNoncurrent	405289
CY2021Q4	lsf	Unrecorded Tax Liabilities UnrecordedTaxLiabilities	0
CY2020Q4	lsf	Unrecorded Tax Liabilities UnrecordedTaxLiabilities	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	887640
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.65
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y5M1D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	33433274
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	56541
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.78
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	100211
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.31
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	96170
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	15.57
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	747800
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.51
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M25D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1143013
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	552512
CY2020	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense	937366
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	26684957
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	56541
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	174078
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense	772832
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	8.12
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y14D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2714963
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	788528
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.42
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y2M1D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4799381
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	174078
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	16.07
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	23434
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	11.34
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	51532
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	11.53
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	887640
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.65
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y5M1D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	33433274
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	660890
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.94
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y6M18D
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	219158
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2282174
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1613520
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M12D
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M20D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5212
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.7129
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y2M23D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y2M23D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0072
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0069
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	5000000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	lsf	Share Based Compensation Arrangement By Share Based Payment Weightedaverage Fair Value Of Options Granted ShareBasedCompensationArrangementByShareBasedPaymentWeightedaverageFairValueOfOptionsGranted	20.78
CY2020	lsf	Share Based Compensation Arrangement By Share Based Payment Weightedaverage Fair Value Of Options Granted ShareBasedCompensationArrangementByShareBasedPaymentWeightedaverageFairValueOfOptionsGranted	18.28
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	5000000
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0
CY2020Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	10000000
CY2020Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.005
CY2021	lsf	Weighted Average Shares Outstanding Subscribed But Unissued WeightedAverageSharesOutstandingSubscribedButUnissued	8320
CY2020	lsf	Weighted Average Shares Outstanding Subscribed But Unissued WeightedAverageSharesOutstandingSubscribedButUnissued	1000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-23870546
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-12850301
CY2021	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	0
CY2020	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	825366
CY2021	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	0
CY2020	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	825366
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-23870546
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14501033
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8983294
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	5546078
CY2021	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	839050
CY2020	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	945027
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.66
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.61
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36810953
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25783226
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10865914
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9180584
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36810953
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25783226
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1268718
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	839659
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9367559
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7396896
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36810953
CY2021Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7153814
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7667075
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6998695
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5559498
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	27379082
CY2021Q4	us-gaap	Gross Profit GrossProfit	2213745
CY2021Q3	us-gaap	Gross Profit GrossProfit	3198839
CY2021Q2	us-gaap	Gross Profit GrossProfit	2181889
CY2021Q1	us-gaap	Gross Profit GrossProfit	1837398
CY2021	us-gaap	Gross Profit GrossProfit	9431871
CY2021Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4398830
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4254124
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4162912
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3643396
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16459262
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	171984
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	242604
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	374853
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	240686
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1030127
CY2021Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4661135
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4014753
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3921289
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3297721
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15894898
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	9231949
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	8511481
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	8459054
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	7181803
CY2021	us-gaap	Operating Expenses OperatingExpenses	33384287
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-7018204
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5312642
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6277165
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5344405
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-23952416
CY2021Q4	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	63458
CY2021Q3	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	10721
CY2021Q2	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	11624
CY2021Q1	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	13901
CY2021	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	99704
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6954746
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5301921
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6265541
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5330504
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23852712
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	68661
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-49777
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-36718
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-17834
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-6886085
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-5351698
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-6302259
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-5330504
CY2021	us-gaap	Profit Loss ProfitLoss	-23870546
CY2021Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.76
CY2021Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.59
CY2021Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.70
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.60
CY2021Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	9067235
CY2021Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	9001912
CY2021Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8967797
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8894495
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7284729
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7490642
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5524630
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5483225
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25783226
CY2020Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5819762
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5734144
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4285128
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3365608
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	19204642
CY2020Q4	us-gaap	Gross Profit GrossProfit	1464967
CY2020Q3	us-gaap	Gross Profit GrossProfit	1756498
CY2020Q2	us-gaap	Gross Profit GrossProfit	1239502
CY2020Q1	us-gaap	Gross Profit GrossProfit	2117617
CY2020	us-gaap	Gross Profit GrossProfit	6578584
CY2020Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3177447
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2218820
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1832443
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1599569
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8828279
CY2020Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	144180
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	102879
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	117797
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	143314
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	508170
CY2020Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2650359
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2816630
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2311501
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2392816
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10171306
CY2020Q4	us-gaap	Operating Expenses OperatingExpenses	5971986
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	5138329
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	4261741
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	4135699
CY2020	us-gaap	Operating Expenses OperatingExpenses	19507755
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4507019
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3381831
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3022239
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2018082
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-12929171
CY2020Q4	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	13423
CY2020Q3	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	26746
CY2020Q2	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	15847
CY2020Q1	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	22854
CY2020	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	78870
CY2020Q4	us-gaap	Profit Loss ProfitLoss	-4493596
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-3355085
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-3006392
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-1995228
CY2020	us-gaap	Profit Loss ProfitLoss	-12850301
CY2020Q4	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	0
CY2020Q3	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	0
CY2020Q2	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	825366
CY2020Q1	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	0
CY2020	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	825366
CY2020Q4	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	0
CY2020Q3	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	645939
CY2020Q2	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	179427
CY2020Q1	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	0
CY2020	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	825366
CY2020Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4493596
CY2020Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4001024
CY2020Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4011185
CY2020Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1995228
CY2020	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-14501033
CY2020Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.51
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.86
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.93
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.47
CY2020Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8876431
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4672041
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4325265
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4281346

Files In Submission

Name	View Source	Status
0000950170-22-003138-index-headers.html	Edgar Link	pending
0000950170-22-003138-index.html	Edgar Link	pending
0000950170-22-003138.txt	Edgar Link	pending
0000950170-22-003138-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
img70933770_0.jpg	Edgar Link	pending
img70933770_1.jpg	Edgar Link	pending
img87287463_0.jpg	Edgar Link	pending
lsf-20211231.htm	Edgar Link	pending
lsf-20211231.xsd	Edgar Link	pending
lsf-20211231_cal.xml	Edgar Link	unprocessable
lsf-20211231_def.xml	Edgar Link	unprocessable
lsf-20211231_htm.xml	Edgar Link	completed
lsf-20211231_lab.xml	Edgar Link	unprocessable
lsf-20211231_pre.xml	Edgar Link	unprocessable
lsf-ex10_13.htm	Edgar Link	pending
lsf-ex21_1.htm	Edgar Link	pending
lsf-ex23_1.htm	Edgar Link	pending
lsf-ex31_1.htm	Edgar Link	pending
lsf-ex31_2.htm	Edgar Link	pending
lsf-ex32_1.htm	Edgar Link	pending
lsf-ex32_2.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LSF
Laird Superfood, Inc. Stock $lsf

2022 Q1 Form 10-K Financial Statement

#000095017022003138 Filed on March 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSF Laird Superfood, Inc. Stock $lsf

2022 Q1 Form 10-K Financial Statement

#000095017022003138 Filed on March 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSF
Laird Superfood, Inc. Stock $lsf